Wikidata

(Q61965920)

English

Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

short name
MEN_BOC (English)
0 references
title
Boceprevir/Peginterferon Alfa (PegIFN α)-2b/Ribavirin (Riba) in Difficult-to-Treat Menopausal Women With Chronic Hepatitis C Genotype 1 (Gt 1), Either Deemed Nonresponders to Peginterferon/Ribavirin or Treatment-naives (MEN_BOC) (English)
0 references
medical condition
hepatitis
0 references
hepatitis C
0 references
country
Italy
0 references
main subject
boceprevir
0 references
start time
November 2011
0 references
end time
December 2013
0 references
number of participants
240
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61965920&oldid=2177777869"